MindRank Begins IND-enabling Studies of its first AI-designed Drug, 8 Months After Program Initiation

/PRNewswire/ -- MindRank AI, an artificial intelligence (AI) driven biotech company, today announced that the company has nominated a preclinical candidate...

Related Keywords

China ,Hangzhou ,Zhejiang ,Zhangming Niu ,Months After Program Initiation ,After Program ,Mindrank Ai ,